Share Price and Basic Stock Data
Last Updated: February 2, 2026, 4:49 pm
| PEG Ratio | 0.38 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alufluoride Ltd operates in the chemicals sector, specifically focusing on inorganic chemicals. As of October 2023, the company’s share price stood at ₹419, with a market capitalization of ₹327 Cr. The firm has demonstrated a robust growth trajectory in revenue, with reported sales of ₹136 Cr for FY 2023, rising to ₹165 Cr in FY 2024. The trailing twelve months (TTM) revenue reached ₹200 Cr, indicating a strong upward trend. Quarterly sales fluctuated, with a notable peak of ₹53.20 Cr in September 2024. However, the most recent quarters displayed variability, with sales of ₹37.64 Cr in December 2023 and ₹45.71 Cr in March 2024. Such fluctuations may reflect seasonal demand or operational challenges, but the overall trend points towards increasing demand for Alufluoride’s products. The company’s operational performance, marked by an operating profit margin (OPM) of 25.44%, reflects efficient cost management amid rising sales, suggesting a solid business model within its sector.
Profitability and Efficiency Metrics
Alufluoride Ltd’s profitability indicators are impressive, with a reported net profit of ₹19 Cr for FY 2023, translating to an earnings per share (EPS) of ₹17.75, which rose to ₹23.41 in FY 2025. The return on equity (ROE) and return on capital employed (ROCE) stood at 20.8% and 23.6%, respectively, showcasing effective utilization of shareholder funds and capital. The company’s operating profit margin (OPM) of 25.44% is significantly higher than the typical sector range, indicating strong operational efficiency. Moreover, the interest coverage ratio (ICR) of 14.44x suggests that the company comfortably met its interest obligations, which is a positive sign of financial health. However, the cash conversion cycle of 76 days indicates potential areas for improvement in inventory and receivables management. Overall, Alufluoride’s financial metrics demonstrate a solid profitability profile, although attention to operational efficiency could further enhance its performance.
Balance Sheet Strength and Financial Ratios
As of the latest reporting period, Alufluoride Ltd reported total assets of ₹149 Cr, with liabilities totaling ₹149 Cr, resulting in a balanced financial position. The company maintains a conservative borrowing strategy, with total borrowings of ₹32 Cr and a debt-to-equity ratio of 0.22, indicating low financial leverage. Reserves have increased to ₹105 Cr, reflecting a strengthening balance sheet. The current ratio of 5.05 and quick ratio of 3.78 suggest a robust liquidity position, allowing the company to cover short-term obligations comfortably. The price-to-book value (P/BV) ratio stood at 3.56x, slightly elevated compared to typical sector levels, indicating that the market has a favorable view of the company’s growth prospects. The asset turnover ratio of 1.36 indicates efficient use of assets to generate revenue. Overall, Alufluoride’s balance sheet exhibits strength, with adequate reserves and low debt levels supporting its ongoing operations.
Shareholding Pattern and Investor Confidence
Alufluoride Ltd’s shareholding structure reflects a stable ownership pattern. Promoters hold a significant 59.93% stake, which provides a solid foundation for governance and long-term strategic direction. However, foreign institutional investors (FIIs) have a minimal presence, at just 0.05%, while domestic institutional investors (DIIs) hold 1.28%. The public shareholding stands at 38.74%, with a growing number of shareholders, increasing from 12,679 in December 2022 to 15,670 by September 2025. This growth in shareholders indicates increasing investor interest in the company. Nevertheless, the low FII participation may suggest caution among international investors regarding the broader market or sector dynamics. The stability in promoter holding alongside increasing public participation could bolster investor confidence, while the limited institutional participation may present a challenge for liquidity in the stock.
Outlook, Risks, and Final Insight
Looking ahead, Alufluoride Ltd appears well-positioned for continued growth, supported by its increasing revenue and strong profitability metrics. However, the company faces risks, including potential fluctuations in raw material prices and operational challenges that could impact profit margins. Additionally, the low foreign institutional investment might limit the stock’s appeal to a broader investor base. The company’s strong balance sheet and efficient operations provide a buffer against economic downturns, yet maintaining operational efficiency will be critical in sustaining margins. Alufluoride could benefit from enhancing its inventory management to reduce the cash conversion cycle. In summary, while the company has demonstrated impressive financial performance and growth potential, it must navigate sector-specific challenges to maximize shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,370 Cr. | 36.5 | 125/33.1 | 59.9 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 13.3 Cr. | 26.7 | 42.9/24.3 | 58.0 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 219 Cr. | 279 | 356/236 | 13.0 | 211 | 2.87 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 7,060 Cr. | 572 | 728/408 | 34.4 | 157 | 0.52 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 339 Cr. | 433 | 503/376 | 14.3 | 144 | 0.69 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,706.13 Cr | 374.78 | 114.26 | 156.25 | 0.49% | 13.95% | 10.65% | 6.18 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 38.01 | 36.84 | 36.73 | 44.63 | 37.64 | 45.71 | 33.71 | 53.20 | 47.60 | 54.01 | 43.76 | 54.83 | 58.59 |
| Expenses | 28.64 | 28.73 | 28.73 | 33.95 | 30.73 | 37.07 | 26.07 | 42.62 | 36.75 | 46.44 | 36.51 | 40.88 | 44.57 |
| Operating Profit | 9.37 | 8.11 | 8.00 | 10.68 | 6.91 | 8.64 | 7.64 | 10.58 | 10.85 | 7.57 | 7.25 | 13.95 | 14.02 |
| OPM % | 24.65% | 22.01% | 21.78% | 23.93% | 18.36% | 18.90% | 22.66% | 19.89% | 22.79% | 14.02% | 16.57% | 25.44% | 23.93% |
| Other Income | 0.33 | 0.37 | 0.24 | 0.53 | 0.38 | 0.91 | 0.65 | 0.43 | 0.13 | -2.02 | 0.34 | 0.38 | 1.15 |
| Interest | 0.82 | 0.77 | 0.82 | 0.81 | 0.77 | 0.73 | 0.69 | 0.52 | 0.62 | 0.64 | 0.77 | 0.62 | 0.57 |
| Depreciation | 2.07 | 1.96 | 2.09 | 2.16 | 2.18 | 2.19 | 2.19 | 2.27 | 2.26 | 2.25 | 2.29 | 2.40 | 2.40 |
| Profit before tax | 6.81 | 5.75 | 5.33 | 8.24 | 4.34 | 6.63 | 5.41 | 8.22 | 8.10 | 2.66 | 4.53 | 11.31 | 12.20 |
| Tax % | 31.57% | 27.48% | 31.89% | 27.55% | 29.95% | 17.19% | 28.28% | 18.98% | 24.94% | 39.47% | 29.80% | 30.15% | 22.62% |
| Net Profit | 4.66 | 4.17 | 3.64 | 5.98 | 3.04 | 5.49 | 3.88 | 6.66 | 6.08 | 1.60 | 3.18 | 7.91 | 9.44 |
| EPS in Rs | 5.96 | 5.33 | 4.65 | 7.65 | 3.89 | 7.02 | 4.96 | 8.52 | 7.77 | 2.05 | 4.07 | 10.11 | 12.07 |
Last Updated: February 3, 2026, 7:16 am
Below is a detailed analysis of the quarterly data for Alufluoride Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 58.59 Cr.. The value appears strong and on an upward trend. It has increased from 54.83 Cr. (Sep 2025) to 58.59 Cr., marking an increase of 3.76 Cr..
- For Expenses, as of Dec 2025, the value is 44.57 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 40.88 Cr. (Sep 2025) to 44.57 Cr., marking an increase of 3.69 Cr..
- For Operating Profit, as of Dec 2025, the value is 14.02 Cr.. The value appears strong and on an upward trend. It has increased from 13.95 Cr. (Sep 2025) to 14.02 Cr., marking an increase of 0.07 Cr..
- For OPM %, as of Dec 2025, the value is 23.93%. The value appears to be declining and may need further review. It has decreased from 25.44% (Sep 2025) to 23.93%, marking a decrease of 1.51%.
- For Other Income, as of Dec 2025, the value is 1.15 Cr.. The value appears strong and on an upward trend. It has increased from 0.38 Cr. (Sep 2025) to 1.15 Cr., marking an increase of 0.77 Cr..
- For Interest, as of Dec 2025, the value is 0.57 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.62 Cr. (Sep 2025) to 0.57 Cr., marking a decrease of 0.05 Cr..
- For Depreciation, as of Dec 2025, the value is 2.40 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 2.40 Cr..
- For Profit before tax, as of Dec 2025, the value is 12.20 Cr.. The value appears strong and on an upward trend. It has increased from 11.31 Cr. (Sep 2025) to 12.20 Cr., marking an increase of 0.89 Cr..
- For Tax %, as of Dec 2025, the value is 22.62%. The value appears to be improving (decreasing) as expected. It has decreased from 30.15% (Sep 2025) to 22.62%, marking a decrease of 7.53%.
- For Net Profit, as of Dec 2025, the value is 9.44 Cr.. The value appears strong and on an upward trend. It has increased from 7.91 Cr. (Sep 2025) to 9.44 Cr., marking an increase of 1.53 Cr..
- For EPS in Rs, as of Dec 2025, the value is 12.07. The value appears strong and on an upward trend. It has increased from 10.11 (Sep 2025) to 12.07, marking an increase of 1.96.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:15 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29 | 22 | 31 | 36 | 50 | 66 | 76 | 38 | 88 | 136 | 165 | 189 | 200 |
| Expenses | 28 | 19 | 27 | 34 | 41 | 56 | 60 | 37 | 74 | 109 | 130 | 152 | 161 |
| Operating Profit | 1 | 2 | 3 | 3 | 9 | 10 | 16 | 2 | 14 | 27 | 34 | 36 | 40 |
| OPM % | 4% | 11% | 10% | 7% | 18% | 15% | 21% | 4% | 16% | 20% | 21% | 19% | 20% |
| Other Income | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 3 | 2 | -1 | -1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 3 | 3 | 2 | 3 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 6 | 7 | 9 | 9 | 9 |
| Profit before tax | 1 | 4 | 3 | 5 | 9 | 11 | 15 | -1 | 5 | 19 | 25 | 24 | 27 |
| Tax % | 34% | 15% | 37% | 25% | 29% | 24% | 29% | -48% | 27% | 28% | 26% | 25% | |
| Net Profit | 1 | 3 | 2 | 3 | 6 | 8 | 10 | -1 | 4 | 14 | 18 | 18 | 19 |
| EPS in Rs | 1.39 | 4.34 | 3.09 | 4.93 | 9.23 | 11.80 | 13.22 | -0.70 | 4.87 | 17.75 | 23.20 | 23.41 | 24.00 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 15% | 0% | 21% | 11% | 13% | 13% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 200.00% | -33.33% | 50.00% | 100.00% | 33.33% | 25.00% | -110.00% | 500.00% | 250.00% | 28.57% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -233.33% | 83.33% | 50.00% | -66.67% | -8.33% | -135.00% | 610.00% | -250.00% | -221.43% | -28.57% |
Alufluoride Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 20% |
| 3 Years: | 29% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 14% |
| 3 Years: | 73% |
| TTM: | 5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 15% |
| 3 Years: | 19% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 16% |
| 3 Years: | 22% |
| Last Year: | 21% |
Last Updated: September 5, 2025, 2:11 pm
Balance Sheet
Last Updated: December 4, 2025, 2:20 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 8 | 10 | 12 | 17 | 26 | 33 | 45 | 44 | 48 | 62 | 79 | 95 | 105 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 32 | 30 | 31 | 24 | 30 | 32 |
| Other Liabilities | 4 | 6 | 5 | 7 | 7 | 9 | 13 | 12 | 14 | 15 | 18 | 16 | 20 |
| Total Liabilities | 20 | 23 | 25 | 31 | 40 | 49 | 80 | 95 | 100 | 115 | 128 | 149 | 165 |
| Fixed Assets | 4 | 3 | 2 | 3 | 5 | 14 | 21 | 26 | 56 | 64 | 63 | 64 | 65 |
| CWIP | 0 | 0 | 0 | 0 | 2 | 4 | 34 | 34 | 2 | 2 | 1 | 5 | 5 |
| Investments | 5 | 5 | 6 | 13 | 17 | 13 | 1 | 6 | 9 | 12 | 26 | 31 | 41 |
| Other Assets | 10 | 15 | 16 | 15 | 15 | 19 | 23 | 29 | 33 | 37 | 39 | 50 | 53 |
| Total Assets | 20 | 23 | 25 | 31 | 40 | 49 | 80 | 95 | 100 | 115 | 128 | 149 | 165 |
Below is a detailed analysis of the balance sheet data for Alufluoride Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Reserves, as of Sep 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 95.00 Cr. (Mar 2025) to 105.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Sep 2025, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 30.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 4.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 165.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 149.00 Cr. (Mar 2025) to 165.00 Cr., marking an increase of 16.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 65.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2025) to 65.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Investments, as of Sep 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2025) to 41.00 Cr., marking an increase of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Mar 2025) to 53.00 Cr., marking an increase of 3.00 Cr..
- For Total Assets, as of Sep 2025, the value is 165.00 Cr.. The value appears strong and on an upward trend. It has increased from 149.00 Cr. (Mar 2025) to 165.00 Cr., marking an increase of 16.00 Cr..
Notably, the Reserves (105.00 Cr.) exceed the Borrowings (32.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.00 | 2.00 | 3.00 | 3.00 | 9.00 | 10.00 | 1.00 | -30.00 | -16.00 | -4.00 | 10.00 | 6.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 32 | 25 | 43 | 40 | 30 | 32 | 15 | 48 | 56 | 37 | 28 | 38 |
| Inventory Days | 50 | 288 | 126 | 74 | 63 | 39 | 47 | 66 | 79 | 66 | 37 | 56 |
| Days Payable | 39 | 111 | 42 | 49 | 39 | 29 | 25 | 38 | 39 | 21 | 28 | 19 |
| Cash Conversion Cycle | 43 | 202 | 128 | 65 | 54 | 42 | 37 | 76 | 96 | 82 | 37 | 76 |
| Working Capital Days | 46 | 98 | 87 | 53 | 34 | 30 | -8 | 35 | 46 | 37 | 15 | 53 |
| ROCE % | 10% | 22% | 19% | 15% | 32% | 27% | 28% | -0% | 9% | 24% | 25% | 24% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 23.13 | 22.59 | 16.39 | 4.50 | -0.70 |
| Diluted EPS (Rs.) | 23.13 | 22.59 | 16.39 | 4.50 | -0.70 |
| Cash EPS (Rs.) | 34.60 | 33.43 | 25.45 | 12.62 | 2.50 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 130.15 | 108.96 | 87.00 | 71.06 | 66.33 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 130.15 | 108.96 | 87.00 | 71.06 | 66.33 |
| Revenue From Operations / Share (Rs.) | 241.06 | 207.03 | 174.04 | 112.47 | 49.22 |
| PBDIT / Share (Rs.) | 45.51 | 45.64 | 36.03 | 17.91 | 3.02 |
| PBIT / Share (Rs.) | 34.04 | 34.60 | 26.55 | 9.79 | -0.18 |
| PBT / Share (Rs.) | 30.89 | 30.57 | 22.84 | 6.34 | -1.36 |
| Net Profit / Share (Rs.) | 23.13 | 22.40 | 15.97 | 4.50 | -0.70 |
| NP After MI And SOA / Share (Rs.) | 23.13 | 22.59 | 16.39 | 4.50 | -0.70 |
| PBDIT Margin (%) | 18.88 | 22.04 | 20.70 | 15.92 | 6.13 |
| PBIT Margin (%) | 14.12 | 16.71 | 15.25 | 8.70 | -0.37 |
| PBT Margin (%) | 12.81 | 14.76 | 13.12 | 5.63 | -2.76 |
| Net Profit Margin (%) | 9.59 | 10.81 | 9.17 | 4.00 | -1.42 |
| NP After MI And SOA Margin (%) | 9.59 | 10.90 | 9.41 | 4.00 | -1.42 |
| Return on Networth / Equity (%) | 17.77 | 20.89 | 18.85 | 6.33 | -1.06 |
| Return on Capital Employeed (%) | 19.98 | 25.47 | 21.77 | 9.31 | -0.17 |
| Return On Assets (%) | 12.20 | 13.76 | 11.23 | 3.52 | -0.57 |
| Long Term Debt / Equity (X) | 0.19 | 0.09 | 0.21 | 0.28 | 0.38 |
| Total Debt / Equity (X) | 0.22 | 0.19 | 0.34 | 0.40 | 0.46 |
| Asset Turnover Ratio (%) | 1.36 | 1.34 | 1.26 | 0.89 | 0.00 |
| Current Ratio (X) | 5.05 | 2.66 | 2.41 | 1.85 | 1.92 |
| Quick Ratio (X) | 3.78 | 2.18 | 1.56 | 1.13 | 1.39 |
| Inventory Turnover Ratio (X) | 12.66 | 7.53 | 6.44 | 6.28 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 8.85 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 5.94 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 91.15 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 94.06 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 14.44 | 11.33 | 9.70 | 5.18 | 2.57 |
| Interest Coverage Ratio (Post Tax) (X) | 8.34 | 6.56 | 5.30 | 2.30 | 0.40 |
| Enterprise Value (Cr.) | 379.89 | 373.36 | 255.20 | 256.35 | 189.40 |
| EV / Net Operating Revenue (X) | 2.02 | 2.31 | 1.87 | 2.91 | 4.92 |
| EV / EBITDA (X) | 10.67 | 10.46 | 9.06 | 18.30 | 80.16 |
| MarketCap / Net Operating Revenue (X) | 1.92 | 2.25 | 1.72 | 2.68 | 4.51 |
| Retention Ratios (%) | 0.00 | 91.14 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 3.56 | 4.32 | 3.45 | 4.24 | 3.35 |
| Price / Net Operating Revenue (X) | 1.92 | 2.25 | 1.72 | 2.68 | 4.51 |
| EarningsYield | 0.04 | 0.04 | 0.05 | 0.01 | 0.00 |
After reviewing the key financial ratios for Alufluoride Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.59 (Mar 24) to 23.13, marking an increase of 0.54.
- For Diluted EPS (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.59 (Mar 24) to 23.13, marking an increase of 0.54.
- For Cash EPS (Rs.), as of Mar 25, the value is 34.60. This value is within the healthy range. It has increased from 33.43 (Mar 24) to 34.60, marking an increase of 1.17.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 130.15. It has increased from 108.96 (Mar 24) to 130.15, marking an increase of 21.19.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 130.15. It has increased from 108.96 (Mar 24) to 130.15, marking an increase of 21.19.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 241.06. It has increased from 207.03 (Mar 24) to 241.06, marking an increase of 34.03.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 45.51. This value is within the healthy range. It has decreased from 45.64 (Mar 24) to 45.51, marking a decrease of 0.13.
- For PBIT / Share (Rs.), as of Mar 25, the value is 34.04. This value is within the healthy range. It has decreased from 34.60 (Mar 24) to 34.04, marking a decrease of 0.56.
- For PBT / Share (Rs.), as of Mar 25, the value is 30.89. This value is within the healthy range. It has increased from 30.57 (Mar 24) to 30.89, marking an increase of 0.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.40 (Mar 24) to 23.13, marking an increase of 0.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.59 (Mar 24) to 23.13, marking an increase of 0.54.
- For PBDIT Margin (%), as of Mar 25, the value is 18.88. This value is within the healthy range. It has decreased from 22.04 (Mar 24) to 18.88, marking a decrease of 3.16.
- For PBIT Margin (%), as of Mar 25, the value is 14.12. This value is within the healthy range. It has decreased from 16.71 (Mar 24) to 14.12, marking a decrease of 2.59.
- For PBT Margin (%), as of Mar 25, the value is 12.81. This value is within the healthy range. It has decreased from 14.76 (Mar 24) to 12.81, marking a decrease of 1.95.
- For Net Profit Margin (%), as of Mar 25, the value is 9.59. This value is within the healthy range. It has decreased from 10.81 (Mar 24) to 9.59, marking a decrease of 1.22.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.59. This value is within the healthy range. It has decreased from 10.90 (Mar 24) to 9.59, marking a decrease of 1.31.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.77. This value is within the healthy range. It has decreased from 20.89 (Mar 24) to 17.77, marking a decrease of 3.12.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.98. This value is within the healthy range. It has decreased from 25.47 (Mar 24) to 19.98, marking a decrease of 5.49.
- For Return On Assets (%), as of Mar 25, the value is 12.20. This value is within the healthy range. It has decreased from 13.76 (Mar 24) to 12.20, marking a decrease of 1.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has increased from 0.09 (Mar 24) to 0.19, marking an increase of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has increased from 0.19 (Mar 24) to 0.22, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.36. It has increased from 1.34 (Mar 24) to 1.36, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 5.05. This value exceeds the healthy maximum of 3. It has increased from 2.66 (Mar 24) to 5.05, marking an increase of 2.39.
- For Quick Ratio (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 2. It has increased from 2.18 (Mar 24) to 3.78, marking an increase of 1.60.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.66. This value exceeds the healthy maximum of 8. It has increased from 7.53 (Mar 24) to 12.66, marking an increase of 5.13.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.85 (Mar 24) to 0.00, marking a decrease of 8.85.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.94 (Mar 24) to 0.00, marking a decrease of 5.94.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.15 (Mar 24) to 0.00, marking a decrease of 91.15.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.06 (Mar 24) to 0.00, marking a decrease of 94.06.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 14.44. This value is within the healthy range. It has increased from 11.33 (Mar 24) to 14.44, marking an increase of 3.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.34. This value is within the healthy range. It has increased from 6.56 (Mar 24) to 8.34, marking an increase of 1.78.
- For Enterprise Value (Cr.), as of Mar 25, the value is 379.89. It has increased from 373.36 (Mar 24) to 379.89, marking an increase of 6.53.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has decreased from 2.31 (Mar 24) to 2.02, marking a decrease of 0.29.
- For EV / EBITDA (X), as of Mar 25, the value is 10.67. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 10.67, marking an increase of 0.21.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.92, marking a decrease of 0.33.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 91.14 (Mar 24) to 0.00, marking a decrease of 91.14.
- For Price / BV (X), as of Mar 25, the value is 3.56. This value exceeds the healthy maximum of 3. It has decreased from 4.32 (Mar 24) to 3.56, marking a decrease of 0.76.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.92, marking a decrease of 0.33.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alufluoride Ltd:
- Net Profit Margin: 9.59%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.98% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.77% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.78
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.3 (Industry average Stock P/E: 114.26)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 9.59%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | Mulagada, Mindi, Vishakapatnam Andhra Pradesh 530012 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yugandhar Meka | Chairman & Ind.Dire (Non-Exe) |
| Mr. Venkat Akkineni | Managing Director |
| Mrs. Jyothsana Akkineni | Executive Director |
| Mr. Aditya Akkineni | WholeTime Director & CEO |
| Mr. K Purushotham Naidu | Director |
| Mr. Ashok Vemulapalli | Non Exe.Non Ind.Director |
| Dr. Ravi Prasad Gorthy | Ind. Non-Executive Director |
| Mr. Sohrab Chinoy Kersasp | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Alufluoride Ltd?
Alufluoride Ltd's intrinsic value (as of 05 February 2026) is ₹474.66 which is 9.62% higher the current market price of ₹433.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹339 Cr. market cap, FY2025-2026 high/low of ₹503/376, reserves of ₹105 Cr, and liabilities of ₹165 Cr.
What is the Market Cap of Alufluoride Ltd?
The Market Cap of Alufluoride Ltd is 339 Cr..
What is the current Stock Price of Alufluoride Ltd as on 05 February 2026?
The current stock price of Alufluoride Ltd as on 05 February 2026 is ₹433.
What is the High / Low of Alufluoride Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alufluoride Ltd stocks is ₹503/376.
What is the Stock P/E of Alufluoride Ltd?
The Stock P/E of Alufluoride Ltd is 14.3.
What is the Book Value of Alufluoride Ltd?
The Book Value of Alufluoride Ltd is 144.
What is the Dividend Yield of Alufluoride Ltd?
The Dividend Yield of Alufluoride Ltd is 0.69 %.
What is the ROCE of Alufluoride Ltd?
The ROCE of Alufluoride Ltd is 23.6 %.
What is the ROE of Alufluoride Ltd?
The ROE of Alufluoride Ltd is 20.8 %.
What is the Face Value of Alufluoride Ltd?
The Face Value of Alufluoride Ltd is 10.0.